PAHCPhibro Animal Health Corporation
$38.29-3.0% 1Y
$38.29
$28.4052 weeks$59.33
The financials
Phibro Animal Health Corporation by the numbers
Phibro Animal Health Corporation (PAHC) reported revenue of $397M in Q4 2026 (quarter ended Jun 30, 2026), up 4.8% from the same quarter a year earlier. That came with a gross margin of 34% and net income of $22M (5.5% of revenue). For the full year FY2026, revenue was $1.52B (+17% year on year) and net income $100M. Its largest product in Q4 2026 was Medicated Feed Additives And Others at $208M, 52% of the disclosed total, well ahead of Mineral Nutrition at 19%. The next results filing is expected around Nov 4, 2026, the same week as a year ago.
| Income statement | Q4 2026 | Q4 2025 | Change |
|---|---|---|---|
| Revenue | $397M | $379M | +4.8% |
| Gross profit | $134M | $110M | +22% |
| Operating income | $48M | $34M | +43% |
| Net income | $22M | $17M | +26% |
| Diluted EPS | $0.53 | $0.43 | +23% |
| Product | Revenue | Share |
|---|---|---|
| Medicated Feed Additives And Others | $208M | 52% |
| Mineral Nutrition | $77M | 19% |
| Nutritional Specialties | $50M | 13% |
| Vaccines | $40M | 10% |
| Performance Products | $22M | 5.6% |
Business segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Jun 2026Total $396.7M (+3.4%)
Mineral Nutrition grew +20% year on yearMedicated Feed Additives And Others +0.53% year on year
Segment Latestquarter on quarteryear on year
- Medicated Feed Additives And Others$207.6M$207.6Mquarter on quarter +0.89%year on year +0.53%+0.89%+0.53%
- Mineral Nutrition$77.0M$77.0Mquarter on quarter +4.9%year on year +20%+4.9%+20%
- Nutritional Specialties$49.9M$49.9Mquarter on quarter +6.6%year on year +5.3%+6.6%+5.3%
- Vaccines$40.0M$40.0Mquarter on quarter +3.7%year on year +3.8%+3.7%+3.8%
- Performance Products$22.2M$22.2Mquarter on quarter +17%year on year +0.59%+17%+0.59%
On our screens:Stocks priced for perfection
Drug Manufacturers, Specialty & Generic
Ranks #8 of 41 by RyuScore